Institute News: Announcements

Seven from MIT elected to American Academy of Arts and Sciences for 2022

by MIT News Office |

Seven MIT faculty members are among more than 250 leaders from academia, the arts, industry, public policy, and research elected to the American Academy of Arts and Sciences, the academy announced Thursday.

One of the nation’s most prestigious honorary societies, the academy is also a leading center for independent policy research. Members contribute to academy publications, as well as studies of science and technology policy, energy and global security, social policy and American institutions, the humanities and culture, and education.

Those elected from MIT this year are:

  • Alberto Abadie, professor of economics and associate director of the Institute for Data, Systems, and Society
  • Regina Barzilay, the School of Engineering Distinguished Professor for AI and Health
  • Roman Bezrukavnikov, professor of mathematics
  • Michale S. Fee, the Glen V. and Phyllis F. Dorflinger Professor and head of the Department of Brain and Cognitive Sciences
  • Dina Katabi, the Thuan and Nicole Pham Professor
  • Ronald T. Raines, the Roger and Georges Firmenich Professor of Natural Products Chemistry
  • Rebecca R. Saxe, the John W. Jarve Professor of Brain and Cognitive Sciences

“We are celebrating a depth of achievements in a breadth of areas,” says David Oxtoby, president of the American Academy. “These individuals excel in ways that excite us and inspire us at a time when recognizing excellence, commending expertise, and working toward the common good is absolutely essential to realizing a better future.”

Since its founding in 1780, the academy has elected leading thinkers from each generation, including George Washington and Benjamin Franklin in the 18th century, Maria Mitchell and Daniel Webster in the 19th century, and Toni Morrison and Albert Einstein in the 20th century. The current membership includes more than 250 Nobel and Pulitzer Prize winners.

Aging Brain Initiative awards fund five new ideas to study, fight neurodegeneration

Anne Trafton |

Neurodegenerative diseases are defined by an increasingly widespread and debilitating death of nervous system cells, but they also share other grim characteristics: Their cause is rarely discernible and they have all eluded cures. To spur fresh, promising approaches and to encourage new experts and expertise to join the field, MIT’s Aging Brain Initiative (ABI) this month awarded five seed grants after a competition among labs across the Institute.

Founded in 2015 by nine MIT faculty members, the ABI promotes research, symposia, and related activities to advance fundamental insights that can lead to clinical progress against neurodegenerative conditions, such as Alzheimer’s disease, with an age-related onset. With an emphasis on spurring research at an early stage before it is established enough to earn more traditional funding, the ABI derives support from philanthropic gifts.

“Solving the mysteries of how health declines in the aging brain and turning that knowledge into effective tools, treatments, and technologies is of the utmost urgency given the millions of people around the world who suffer with no meaningful treatment options,” says ABI director and co-founder Li-Huei Tsai, the Picower Professor of Neuroscience in The Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences. “We were very pleased that many groups across MIT were eager to contribute their expertise and creativity to that goal. From here, five teams will be able to begin testing their innovative ideas and the impact they could have.”

To address the clinical challenge of accurately assessing cognitive decline during Alzheimer’s disease progression and healthy aging, a team led by Thomas Heldt, associate professor of electrical and biomedical engineering in the Department of Electrical Engineering and Computer Science (EECS) and the Institute for Medical Engineering and Science, proposes to use artificial intelligence tools to bring diagnostics based on eye movements during cognitive tasks to everyday consumer electronics such as smartphones and tablets. By moving these capabilities to common at-home platforms, the team, which also includes EECS Associate Professor Vivian Sze, hopes to increase monitoring beyond what can only be intermittently achieved with high-end specialized equipment and dedicated staffing in specialists’ offices. The team will pilot their technology in a small study at Boston Medical Center in collaboration with neurosurgeon James Holsapple.

Institute Professor Ann Graybiel’s lab in the Department of Brain and Cognitive Sciences (BCS) and the McGovern Institute for Brain Research will test the hypothesis that mutations on a specific gene may lead to the early emergence of Alzheimer’s disease (AD) pathology in the striatum. That’s a a brain region crucial for motivation and movement that is directly and severely impacted by other neurodegenerative disorders including Parkinson’s and Huntington’s diseases, but that has largely been unstudied in Alzheimer’s. By editing the mutations into normal and AD-modeling mice, Research Scientist Ayano Matsushima and Graybiel hope to determine whether and how pathology, such as the accumulation of amyloid proteins, may result. Determining that could provide new insight into the progression of disease and introduce a new biomarker in a region that virtually all other studies have overlooked.

Numerous recent studies have highlighted a potential role for immune inflammation in Alzheimer’s disease. A team led by Gloria Choi, the Mark Hyman Jr. Associate Professor in BCS and The Picower Institute for Learning and Memory, will track one potential source of such activity by determining whether the brain’s meninges, which envelop the brain, becomes a means for immune cells activated by gut bacteria to circulate near the brain, where they may release signaling molecules that promote Alzheimer’s pathology. Working in mice, Choi’s lab will test whether such activity is prone to increase in Alzheimer’s and whether it contributes to disease.

A collaboration led by Peter Dedon, the Singapore Professor in MIT’s Department of Biological Engineering, will explore whether Alzheimer’s pathology is driven by dysregulation of transfer RNAs (tRNAs) and the dozens of natural tRNA modifications in the epitranscriptome, which play a key role in the process by which proteins are assembled based on genetic instructions. With Benjamin Wolozin of Boston University, Sherif Rashad of Tohoku University in Japan, and Thomas Begley of the State University of New York at Albany, Dedon will assess how the tRNA pool and epitranscriptome may differ in Alzheimer’s model mice and whether genetic instructions mistranslated because of tRNA dysregulation play a role in Alzheimer’s disease.

With her seed grant, Ritu Raman, the d’Arbeloff Assistant Professor of Mechanical Engineering, is launching an investigation of possible disruption of intercellular messages in amyotrophic lateral sclerosis (ALS), a terminal condition in which motor neuron causes loss of muscle control. Equipped with a new tool to finely sample interstitial fluid within tissues, Raman’s team will be able to monitor and compare cell-cell signaling in models of the junction between nerve and muscle. These models will be engineered from stem cells derived from patients with ALS. By studying biochemical signaling at the junction the lab hopes to discover new targets that could be therapeutically modified.

Major support for the seed grants, which provide each lab with $100,000, came from generous gifts by David Emmes SM ’76; Kathleen SM ’77, PhD ’86 and Miguel Octavio; the Estate of Margaret A. Ridge-Pappis, wife of the late James Pappis ScD ’59; the Marc Haas Foundation; and the family of former MIT President Paul Gray ’54, SM ’55, ScD ‘60, with additional funding from many annual fund donors to the Aging Brain Initiative Fund.

Three from MIT awarded 2022 Paul and Daisy Soros Fellowships for New Americans

by Julia Mongo | Office of Distinguished Fellowships |

MIT graduate student Fernanda De La Torre, alumna Trang Luu ’18, SM ’20, and senior Syamantak Payra are recipients of the 2022 Paul and Daisy Soros Fellowships for New Americans.

De La Torre, Luu, and Payra are among 30 New Americans selected from a pool of over 1,800 applicants. The fellowship honors the contributions of immigrants and children of immigrants by providing $90,000 in funding for graduate school.

Students interested in applying to the P.D. Soros Fellowship for future years may contact Kim Benard, associate dean of distinguished fellowships in Career Advising and Professional Development.

Fernanda De La Torre

Fernanda De La Torre is a PhD student in the Department of Brain and Cognitive Sciences. With Professor Josh McDermott, she studies how we integrate vision and sound, and with Professor Robert Yang, she develops computational models of imagination.

De La Torre spent her early childhood with her younger sister and grandmother in Guadalajara, Mexico. At age 12, she crossed the Mexican border to reunite with her mother in Kansas City, Missouri. Shortly after, an abusive home environment forced De La Torre to leave her family and support herself throughout her early teens.

Despite her difficult circumstances, De La Torre excelled academically in high school. By winning various scholarships that would discretely take applications from undocumented students, she was able to continue her studies in computer science and mathematics at Kansas State University. There, she became intrigued by the mysteries of the human mind. During college, De La Torre received invaluable mentorship from her former high school principal, Thomas Herrera, who helped her become documented through the Violence Against Women Act. Her college professor, William Hsu, supported her interests in artificial intelligence and encouraged her to pursue a scientific career.

After her undergraduate studies, De La Torre won a post-baccalaureate fellowship from the Department of Brain and Cognitive Sciences at MIT, where she worked with Professor Tomaso Poggio on the theory of deep learning. She then transitioned into the department’s PhD program. Beyond contributing to scientific knowledge, De La Torre plans to use science to create spaces where all people, including those from backgrounds like her own, can innovate and thrive.

She says: “Immigrants face many obstacles, but overcoming them gives us a unique strength: We learn to become resilient, while relying on friends and mentors. These experiences foster both the desire and the ability to pay it forward to our community.”

Trang Luu

Trang Luu graduated from MIT with a BS in mechanical engineering in 2018, and a master of engineering degree in 2020. Her Soros award will support her graduate studies at Harvard University in the MBA/MS engineering sciences program.

Born in Saigon, Vietnam, Luu was 3 when her family immigrated to Houston, Texas. Watching her parents’ efforts to make a living in a land where they did not understand the culture or speak the language well, Luu wanted to alleviate hardship for her family. She took full responsibility for her education and found mentors to help her navigate the American education system. At home, she assisted her family in making and repairing household items, which fueled her excitement for engineering.

As an MIT undergraduate, Luu focused on assistive technology projects, applying her engineering background to solve problems impeding daily living. These projects included a new adaptive socket liner for below-the-knee amputees in Kenya, Ethiopia, and Thailand; a walking stick adapter for wheelchairs; a computer head pointer for patients with limited arm mobility, a safer makeshift cook stove design for street vendors in South Africa; and a quicker method to test new drip irrigation designs. As a graduate student in MIT D-Lab under the direction of Professor Daniel Frey, Luu was awarded a National Science Foundation Graduate Research Fellowship. In her graduate studies, Luu researched methods to improve evaporative cooling devices for off-grid farmers to reduce rapid fruit and vegetable deterioration.

These projects strengthened Luu’s commitment to innovating new technology and devices for people struggling with basic daily tasks. During her senior year, Luu collaborated on developing a working prototype of a wearable device that noninvasively reduces hand tremors associated with Parkinson’s disease or essential tremor. Observing patients’ joy after their tremors stopped compelled Luu and three co-founders to continue developing the device after college. Four years later, Encora Therapeutics has accomplished major milestones, including Breakthrough Device designation by the U.S. Food and Drug Administration.

Syamantak Payra

Hailing from Houston, Texas, Syamantak Payra is a senior majoring in electrical engineering and computer science, with minors in public policy and entrepreneurship and innovation. He will be pursuing a PhD in engineering at Stanford University, with the goal of creating new biomedical devices that can help improve daily life for patients worldwide and enhance health care outcomes for decades to come.

Payra’s parents had emigrated from India, and he grew up immersed in his grandparents’ rich Bengali culture. As a high school student, he conducted projects with NASA engineers at Johnson Space Center, experimented at home with his scientist parents, and competed in spelling bees and science fairs across the United States. Through these avenues and activities, Syamantak not only gained perspectives on bridging gaps between people, but also found passions for language, scientific discovery, and teaching others.

After watching his grandmother struggle with asthma and chronic obstructive pulmonary disease and losing his baby brother to brain cancer, Payra devoted himself to trying to use technology to solve health-care challenges. Payra’s proudest accomplishments include building a robotic leg brace for his paralyzed teacher and conducting free literacy workshops and STEM outreach programs that reached nearly a thousand underprivileged students across the Greater Houston Area.

At MIT, Payra has worked in Professor Yoel Fink’s research laboratory, creating digital sensor fibers that have been woven into intelligent garments that can assist in diagnosing illnesses, and in Professor Joseph Paradiso’s research laboratory, where he contributed to next-generation spacesuit prototypes that better protect astronauts on spacewalks. Payra’s research has been published by multiple scientific journals, and he was inducted into the National Gallery of America’s Young Inventors.

David Ginty named winner of 2022 Scolnick Prize

by Jill Crittenden |

Harvard neurobiologist David Ginty, winner of the 2022 Scolnick Prize.

The McGovern Institute for Brain Research announced today that Harvard neurobiologist David D. Ginty has been selected for the 2022 Edward M. Scolnick Prize in Neuroscience. Ginty, who is the Edward R. and Anne G. Lefler Professor of Neurobiology at Harvard Medical School, is being recognized for his fundamental discoveries into the neural mechanisms underlying the sense of touch. The Scolnick Prize is awarded annually by the McGovern Institute for outstanding advances in neuroscience.

“David Ginty has made seminal contributions in basic research that also have important translational implications,” says Robert Desimone, McGovern Institute Director and chair of the selection committee. “His rigorous research has led us to understand how the peripheral nervous system encodes the overall perception of touch, and how molecular mechanisms underlying this can fail in disease states.”

Ginty obtained his PhD in 1989 with Edward Seidel where he studied cell proliferation factors. He went on to a postdoctoral fellowship researching nerve growth factor with John Wagner at the Dana-Farber Cancer Institute and, upon Wagner’s departure to Cornell, transferred to Michael Greenberg’s lab at Harvard Medical School. There, he dissected intracellular signaling pathways for neuronal growth factors and neurotransmitters and developed key antibody reagents to detect activated forms of transcription factors. These antibody tools are now used by labs around the world in the research of neuronal plasticity and brain disorders, including Alzheimer’s disease and schizophrenia.

In 1995, Ginty started his own laboratory at Johns Hopkins University with a focus on the development and functional organization of the peripheral nervous system. Ginty’s group created and applied the latest genetic engineering techniques in mice to uncover how the peripheral nervous system develops and is organized at the molecular, cellular and circuit levels to perceive touch. Most notably, using gene targeting combined with electrophysiological, behavioral and anatomical analyses, the Ginty lab untangled properties and functions of the different types of touch neurons, termed low- and high-threshold mechanoreceptors, that convey distinct aspects of stimulus information from the skin to the central nervous system. Ginty and colleagues also discovered organizational principles of spinal cord and brainstem circuits dedicated to touch information processing, and that integration of signals from the different mechanoreceptor types begins within spinal cord networks before signal transmission to the brain.

In 2013, Ginty joined the faculty of Harvard Medical School where his team applied their genetic tools and techniques to probe the neural basis of touch sensitivity disorders. They discovered properties and functions of peripheral sensory neurons, spinal cord circuits, and ascending pathways that transmit noxious, painful stimuli from the periphery to the brain. They also asked whether abnormalities in peripheral nervous system function lead to touch over-reactivity in cases of autism or in neuropathic pain caused by nerve injury, chemotherapy, or diabetes, where even a soft touch can be aversive or painful. His team found that sensory abnormalities observed in several mouse models of autism spectrum disorder could be traced to peripheral mechanosensory neurons. They also found that reducing the activity of peripheral sensory neurons prevented tactile over-reactivity in these models and even, in some cases, lessened anxiety and abnormal social behaviors. These findings provided a plausible explanation for how sensory dysfunction may contribute to physiological and cognitive impairments in autism. Importantly, this laid the groundwork for a new approach and initiative to identify new potential therapies for disorders of touch and pain.

Ginty was named a Howard Hughes Medical Institute Investigator in 2000 and was elected to the American Academy of Arts and Sciences in 2015 and the National Academy of Sciences in 2017. He shared Columbia University’s Alden W. Spencer Prize with Ardem Patapoutian in 2017 and was awarded the Society for Neuroscience Julius Axelrod Prize in 2021. Ginty is also known for exceptional mentorship. He directed the neuroscience graduate program at Johns Hopkins from 2006 to 2013 and now serves as the associate director of Harvard’s neurobiology graduate program.

The McGovern Institute will award the Scolnick Prize to Ginty on Wednesday, June 1, 2022. At 4:00 pm he will deliver a lecture entitled “The sensory neurons of touch: beauty is skin deep,” to be followed by a reception at the McGovern Institute, 43 Vassar Street (building 46, room 3002) in Cambridge. The event is free and open to the public; registration is required.

School of Science announces 2022 Infinite Expansion Awards

by MIT School of Science |

The MIT School of Science has announced eight postdocs and research scientists as recipients of the 2022 Infinite Expansion Award.

The award, formerly known as the Infinite Kilometer Award, was created in 2012 to highlight extraordinary members of the MIT science community. The awardees are nominated not only for their research, but for going above and beyond in mentoring junior colleagues, participating in educational programs, and contributing to their departments, labs, and research centers, the school, and the Institute.

The 2022 School of Science Infinite Expansion winners are:

  • Héctor de Jesús-Cortés, a postdoc in the Picower Institute for Learning and Memory, nominated by professor and Department of Brain and Cognitive Sciences (BCS) head Michale Fee, professor and McGovern Institute for Brain Research Director Robert Desimone, professor and Picower Institute Director Li-Huei Tsai, professor and associate BCS head Laura Schulz, associate professor and associate BCS head Joshua McDermott, and professor and BCS Postdoc Officer Mark Bear for his “awe-inspiring commitment of time and energy to research, outreach, education, mentorship, and community;”
  • Harold Erbin, a postdoc in the Laboratory for Nuclear Science’s Institute for Artificial Intelligence and Fundamental Interactions (IAIFI), nominated by professor and IAIFI Director Jesse Thaler, associate professor and IAIFI Deputy Director Mike Williams, and associate professor and IAIFI Early Career and Equity Committee Chair Tracy Slatyer for “provid[ing] exemplary service on the IAIFI Early Career and Equity Committee” and being “actively involved in many other IAIFI community building efforts;”
  • Megan Hill, a postdoc in the Department of Chemistry, nominated by Professor Jeremiah Johnson for being an “outstanding scientist” who has “also made exceptional contributions to our community through her mentorship activities and participation in Women in Chemistry;”
  • Kevin Kuns, a postdoc in the Kavli Institute for Astrophysics and Space Research, nominated by Associate Professor Matthew Evans for “consistently go[ing] beyond expectations;”
  • Xingcheng Lin, a postdoc in the Department of Chemistry, nominated by Associate Professor Bin Zhang for being “very talented, extremely hardworking, and genuinely enthusiastic about science;”
  • Alexandra Pike, a postdoc in the Department of Biology, nominated by Professor Stephen Bell for “not only excel[ing] in the laboratory” but also being “an exemplary citizen in the biology department, contributing to teaching, community, and to improving diversity, equity, and inclusion in the department;”
  • Nora Shipp, a postdoc with the Kavli Institute for Astrophysics and Space Research, nominated by Assistant Professor Lina Necib for being “independent, efficient, with great leadership qualities” with “impeccable” research; and
  • Jakob Voigts, a research scientist in the McGovern Institute for Brain Research, nominated by Associate Professor Mark Harnett and his laboratory for “contribut[ing] to the growth and development of the lab and its members in numerous and irreplaceable ways.”

Winners are honored with a monetary award and will be celebrated with family, friends, and nominators at a later date, along with recipients of the Infinite Mile Award.

Five MIT faculty elected 2021 AAAS Fellows

by MIT News Office |

Five MIT faculty members have been elected as fellows of the American Association for the Advancement of Science (AAAS).

The 2021 class of AAAS Fellows includes 564 scientists, engineers, and innovators spanning 24 scientific disciplines who are being recognized for their scientifically and socially distinguished achievements.

Mircea Dincă is the W. M. Keck Professor of Energy in the Department of Chemistry. His group’s research focuses on addressing challenges related to the storage and consumption of energy, and global environmental concerns. Central to these efforts are the synthesis of novel organic-inorganic hybrid materials and the manipulation of their electrochemical and photophysical properties, with a current emphasis on porous materials and extended one-dimensional van der Waals materials.

Guoping Feng is the James W. and Patricia T. Poitras Professor of Neuroscience in the Department of Brain and Cognitive Sciences, associate director of MIT’s McGovern Institute for Brain Research, director of Model Systems and Neurobiology at the Stanley Center for Psychiatric Research, and an institute member of the Broad Institute of MIT and Harvard. His research is devoted to understanding the development and function of synapses in the brain and how synaptic dysfunction may contribute to neurodevelopmental and psychiatric disorders. By understanding the molecular, cellular, and circuitry mechanisms of these disorders, Feng hopes his work will eventually lead to the development of new and effective treatments for the millions of people suffering from these devastating diseases.

David Shoemaker is a senior research scientist with the MIT Kavli Institute for Astrophysics and Space Research. His work is focused on gravitational-wave observation and includes developing technologies for the detectors (LIGO, LISA), developing proposals for new instruments (Cosmic Explorer), managing the teams to build them and the consortia which exploit the data (LIGO Scientific Collaboration, LISA Consortium), and supporting the overall growth of the field (Gravitational-Wave International Committee).

Ian Hunter is the Hatsopoulos Professor of Mechanical Engineering and runs the Bioinstrumentation Lab at MIT. His main areas of research are instrumentation, microrobotics, medical devices, and biomimetic materials. Over the years he and his students have developed many instruments and devices including: confocal laser microscopes, scanning tunneling electron microscopes, miniature mass spectrometers, new forms of Raman spectroscopy, needle-free drug delivery technologies, nano- and micro-robots, microsurgical robots, robotic endoscopes, high-performance Lorentz force motors, and microarray technologies for massively parallel chemical and biological assays.

Evelyn N. Wang is the Ford Professor of Engineering and head of the Department of Mechanical Engineering. Her research program combines fundamental studies of micro/nanoscale heat and mass transport processes with the development of novel engineered structures to create innovative solutions in thermal management, energy, and water harvesting systems. Her work in thermophotovoltaics was named to Technology Review’s lists of Biggest Clean Energy Advances, in 2016, and Ten Breakthrough Technologies, in 2017, and to the Department of Energy Frontiers Research Center’s Ten of Ten awards. Her work extracting water from air has won her the title of 2017 Foreign Policy’s Global ReThinker and the 2018 Eighth Prince Sultan bin Abdulaziz International Prize for Water.

National Academy of Sciences honors cognitive neuroscientist Nancy Kanwisher

by Julie Pryor |

MIT neuroscientist and McGovern Investigator Nancy Kanwisher. Photo: Jussi Puikkonen/KNAW

The National Academy of Sciences (NAS) has announced today that Nancy Kanwisher, the Walter A. Rosenblith Professor of Cognitive Neuroscience in MIT’s Department of Brain and Cognitive Sciences, has received the 2022 NAS Award in the Neurosciences for her “pioneering research into the functional organization of the human brain.” The $25,000 prize, established by the Fidia Research Foundation, is presented every three years to recognize “extraordinary contributions to the neuroscience fields.”

“I am deeply honored to receive this award from the NAS,” says Kanwisher, who is also an investigator in MIT’s McGovern Institute and a member of the Center for Brains, Minds and Machines. “It has been a profound privilege, and a total blast, to watch the human brain in action as these data began to reveal an initial picture of the organization of the human mind. But the biggest joy has been the opportunity to work with the incredible group of talented young scientists who actually did the work that this award recognizes.”

A window into the mind

Kanwisher is best known for her landmark insights into how humans recognize and process faces. Psychology had long-suggested that recognizing a face might be distinct from general object recognition. But Kanwisher galvanized the field in 1997 with her seminal discovery that the human brain contains a small region specialized to respond only to faces. The region, which Kanwisher termed the fusiform face area (FFA), became activated when subjects viewed images of faces in an MRI scanner, but not when they looked at scrambled faces or control stimuli.

Since her 1997 discovery (now the most highly cited manuscript in its area), Kanwisher and her students have applied similar methods to find brain specializations for the recognition of scenes, the mental states of others, language, and music. Taken together, her research provides a compelling glimpse into the architecture of the brain, and, ultimately, what makes us human.

“Nancy’s work over the past two decades has argued that many aspects of human cognition are supported by specialized neural circuitry, a conclusion that stands in contrast to our subjective sense of a singular mental experience,” says McGovern Institute Director Robert Desimone. “She has made profound contributions to the psychological and cognitive sciences and I am delighted that the National Academy of Sciences has recognized her outstanding achievements.”

One-in-a-million mentor

Beyond the lab, Kanwisher has a reputation as a tireless communicator and mentor who is actively engaged in the policy implications of brain research. The statistics speak for themselves: her 2014 TED talk, “A Neural portrait of the human mind” has been viewed over a million times online and her introductory MIT OCW course on the human brain has generated more than nine million views on YouTube.

Nancy Kanwisher works with researchers from her lab in MIT’s Martinos Imaging Center. Photo: Kris Brewer

Kanwisher also has an exceptional track record in training women scientists who have gone on to successful independent research careers, in many cases becoming prominent figures in their own right.

“Nancy is the one-in-a-million mentor, who is always skeptical of your ideas and your arguments, but immensely confident of your worth,” says Rebecca Saxe, John W. Jarve (1978) Professor of Brain and Cognitive Sciences, investigator at the McGovern Institute, and associate dean of MIT’s School of Science. Saxe was a graduate student in Kanwisher’s lab where she earned her PhD in cognitive neuroscience in 2003. “She has such authentic curiosity,” Saxe adds. “It’s infectious and sustaining. Working with Nancy was a constant reminder of why I wanted to be a scientist.”

The NAS will present Kanwisher with the award during its annual meeting on May 1, 2022 in Washington, DC. The event will be webcast live. Kanwisher plans to direct her prize funds to the non-profit organization Malengo, established by a former student and which provides quality undergraduate education to individuals who would otherwise not be able to afford it.

MIT response to Wall Street Journal opinion essay

by Robert Desimone, McGovern Institute | Nergis Mavalvala, MIT School of Science | Maria T. Zuber, MIT Office of the Vice President for Research |

Following is an open statement in response to “Is MIT’s Research Helping the Chinese Military?”, an opinion essay by Michelle Bethel posted by the Wall Street Journal on Dec. 10, 2021. This statement is jointly from Prof. Robert Desimone, director of the McGovern Institute for Brain Research at MIT, Prof. Nergis Mavalvala, dean of MIT’s School of Science, and Prof. Maria T. Zuber, vice president for research at MIT.  

Ms. Bethel is absolutely right that research relationships with institutions in China require the most serious care and consideration. MIT brings a thorough and rigorous approach to these matters.

First let us be clear about the work of the MIT McGovern Institute for Brain Research. Of the dozens of research projects currently under way at the McGovern Institute, there is one active research collaboration with China. It involves better identifying and ultimately developing treatments for severe forms of autism or neurological disorders that often render individuals unable to speak and frequently require lifelong care. That project was thoroughly vetted and approved by the U.S. National Institutes of Health in 2019. MIT receives no funding from China for this research, and all findings will be published in peer-reviewed journals, meaning that they are open to medical researchers anywhere in the world. This is the collaboration with the Shenzhen Institute of Advanced Technology that Ms. Bethel referenced in vague terms.

This does not eliminate general concerns about how research may be conducted or used, however. That’s why MIT has strong processes for evaluating and managing the risks of research involving countries, including China, whose behavior affects U.S. national and economic security. Every proposed engagement that involves an organization or funding source from China, once it has been evaluated for compliance with U.S. law and regulation, is further reviewed by committees of senior administrators to consider risks related to national security, economic competitiveness, and civil and human rights. Projects have been variously turned down, modified, or approved under this process.

Ms. Bethel raises important points with respect to U.S.-China relations – but not with respect to the work of the McGovern Institute. We regret that Ms. Bethel felt it necessary to step away from the McGovern, but we respect her views and continue in conversation with her. We note that two other members of the McGovern family, including the McGovern Institute’s co-founder and another daughter, continue to proudly serve on the McGovern board. We are grateful to all three family members.

MIT Future Founders Initiative announces prize competition to promote female entrepreneurs in biotech

Anne Trafton |

In a fitting sequel to its entrepreneurship “boot camp” educational lecture series last fall, the MIT Future Founders Initiative has announced the MIT Future Founders Prize Competition, supported by Northpond Ventures, and named the MIT faculty cohort that will participate in this year’s competition. The Future Founders Initiative was established in 2020 to promote female entrepreneurship in biotech.

Despite increasing representation at MIT, female science and engineering faculty found biotech startups at a disproportionately low rate compared with their male colleagues, according to research led by the initiative’s founders, MIT Professor Sangeeta Bhatia, MIT Professor and President Emerita Susan Hockfield, and MIT Amgen Professor of Biology Emerita Nancy Hopkins. In addition to highlighting systemic gender imbalances in the biotech pipeline, the initiative’s founders emphasize that the dearth of female biotech entrepreneurs represents lost opportunities for society as a whole — a bottleneck in the proliferation of publicly accessible medical and technological innovation.

“A very common myth is that representation of women in the pipeline is getting better with time … We can now look at the data … and simply say, ‘that’s not true’,” said Bhatia, who is the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, and a member of MIT’s Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science, in an interview for the March/April 2021 MIT Faculty Newsletter. “We need new solutions. This isn’t just about waiting and being optimistic.”

Inspired by generous funding from Northpond Labs, the research and development-focused affiliate of Northpond Ventures, and by the success of other MIT prize incentive competitions such as the Climate Tech and Energy Prize, the Future Founders Initiative Prize Competition will be structured as a learning cohort in which participants will be supported in commercializing their existing inventions with instruction in market assessments, fundraising, and business capitalization, as well as other programming. The program, which is being run as a partnership between the MIT School of Engineering and the Martin Trust Center for MIT Entrepreneurship, provides hands-on opportunities to learn from industry leaders about their experiences, ranging from licensing technology to creating early startup companies. Bhatia and Kit Hickey, an entrepreneur-in-residence at the Martin Trust Center and senior lecturer at the MIT Sloan School of Management, are co-directors of the program.

“The competition is an extraordinary effort to increase the number of female faculty who translate their research and ideas into real-world applications through entrepreneurship,” says Anantha Chandrakasan, dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science. “Our hope is that this likewise serves as an opportunity for participants to gain exposure and experience to the many ways in which they could achieve commercial impact through their research.”

At the end of the program, the cohort members will pitch their ideas to a selection committee composed of MIT faculty, biotech founders, and venture capitalists. The grand prize winner will receive $250,000 in discretionary funds, and two runners-up will receive $100,000. The winners will be announced at a showcase event, at which the entire cohort will present their work. All participants will also receive a $10,000 stipend for participating in the competition.

“The biggest payoff is not identifying the winner of the competition,” says Bhatia. “Really, what we are doing is creating a cohort … and then, at the end, we want to create a lot of visibility for these women and make them ‘top of mind’ in the community.”

The Selection Committee members for the MIT Future Founders Prize Competition are:

  • Bill Aulet, professor of the practice in the MIT Sloan School of Management and managing director of the Martin Trust Center for MIT Entrepreneurship
  • Sangeeta Bhatia, the John and Dorothy Wilson Professor of Electrical Engineering and Computer Science at MIT; a member of MIT’s Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science; and founder of Hepregen, Glympse Bio, and Satellite Bio
  • Kit Hickey, senior lecturer in the MIT Sloan School of Management and entrepreneur-in-residence at the Martin Trust Center
  • Susan Hockfield, MIT president emerita and professor of neuroscience
  • Andrea Jackson, director at Northpond Ventures
  • Harvey Lodish, professor of biology and biomedical engineering at MIT and founder of Genzyme, Millennium, and Rubius
  • Fiona Murray, associate dean for innovation and inclusion in the MIT Sloan School of Management; the William Porter Professor of Entrepreneurship; co-director of the MIT Innovation Initiative; and faculty director of the MIT Legatum Center
  • Amy Schulman, founding CEO of Lyndra Therapeutics and partner at Polaris Partners
  • Nandita Shangari, managing director at Novartis Venture Fund

“As an investment firm dedicated to supporting entrepreneurs, we are acutely aware of the limited number of companies founded and led by women in academia. We believe humanity should be benefiting from brilliant ideas and scientific breakthroughs from women in science, which could address many of the world’s most pressing problems. Together with MIT, we are providing an opportunity for women faculty members to enhance their visibility and gain access to the venture capital ecosystem,” says Andrea Jackson, director at Northpond Ventures.

“This first cohort is representative of the unrealized opportunity this program is designed to capture. While it will take a while to build a robust community of connections and role models, I am pleased and confident this program will make entrepreneurship more accessible and inclusive to our community, which will greatly benefit society,” says Susan Hockfield, MIT president emerita.

The MIT Future Founders Prize Competition cohort members were selected from schools across MIT, including the School of Science, the School of Engineering, and Media Lab within the School of Architecture and Planning. They are:

Polina Anikeeva is professor of materials science and engineering and brain and cognitive sciences, an associate member of the McGovern Institute for Brain Research, and the associate director of the Research Laboratory of Electronics. She is particularly interested in advancing the possibility of future neuroprosthetics, through biologically-informed materials synthesis, modeling, and device fabrication. Anikeeva earned her BS in biophysics from St. Petersburg State Polytechnic University and her PhD in materials science and engineering from MIT.

Natalie Artzi is principal research scientist in the Institute of Medical Engineering and Science and an assistant professor in the department of medicine at Brigham and Women’s Hospital. Through the development of smart materials and medical devices, her research seeks to “personalize” medical interventions based on the specific presentation of diseased tissue in a given patient. She earned both her BS and PhD in chemical engineering from the Technion-Israel Institute of Technology.

Laurie A. Boyer is professor of biology and biological engineering in the Department of Biology. By studying how diverse molecular programs cross-talk to regulate the developing heart, she seeks to develop new therapies that can help repair cardiac tissue. She earned her BS in biomedical science from Framingham State University and her PhD from the University of Massachusetts Medical School.

Tal Cohen is associate professor in the departments of Civil and Environmental Engineering and Mechanical Engineering. She wields her understanding of how materials behave when they are pushed to their extremes to tackle engineering challenges in medicine and industry. She earned her BS, MS, and PhD in aerospace engineering from the Technion-Israel Institute of Technology.

Canan Dagdeviren is assistant professor of media arts and sciences and the LG Career Development Professor of Media Arts and Sciences. Her research focus is on creating new sensing, energy harvesting, and actuation devices that can be stretched, wrapped, folded, twisted, and implanted onto the human body while maintaining optimal performance. She earned her BS in physics engineering from Hacettepe University, her MS in materials science and engineering from Sabanci University, and her PhD in materials science and engineering from the University of Illinois at Urbana-Champaign.

Ariel Furst is the Raymond (1921) & Helen St. Laurent Career Development Professor in the Department of Chemical Engineering. Her research addresses challenges in global health and sustainability, utilizing electrochemical methods and biomaterials engineering. She is particularly interested in new technologies that detect and treat disease. Furst earned her BS in chemistry at the University of Chicago and her PhD at Caltech.

Kristin Knouse is assistant professor in the Department of Biology and the Koch Institute for Integrative Cancer Research. She develops tools to investigate the molecular regulation of organ injury and regeneration directly within a living organism with the goal of uncovering novel therapeutic avenues for diverse diseases. She earned her BS in biology from Duke University, her PhD and MD through the Harvard and MIT MD-PhD program.

Elly Nedivi is the William R. (1964) & Linda R. Young Professor of Neuroscience at the Picower Institute for Learning and Memory with joint appointments in the departments of Brain and Cognitive Sciences and Biology. Through her research of neurons, genes, and proteins, Nedivi focuses on elucidating the cellular mechanisms that control plasticity in both the developing and adult brain. She earned her BS in biology from Hebrew University and her PhD in neuroscience from Stanford University.

Ellen Roche is associate professor in the Department of Mechanical Engineering and Institute of Medical Engineering and Science, and the W.M. Keck Career Development Professor in Biomedical Engineering. Borrowing principles and design forms she observes in nature, Roche works to develop implantable therapeutic devices that assist cardiac and other biological function. She earned her bachelor’s degree in biomedical engineering from the National University of Ireland at Galway, her MS in bioengineering from Trinity College Dublin, and her PhD from Harvard University.